30 Sept 2026
Drug patents in India: How they work and when govt can override them
India gives drug makers patent protection for 20 years. After that, the same medicine can be made as a generic, if other regulatory rules are met. The law also lets the government step in and allow compulsory licensing or government use when access to medicines becomes a public concern. This matters if you sell or buy medicines, because generic versions may become available.
Key Statutory Highlights
- Drug patents in India generally give the maker protection for 20 years.
- Once patent protection expires, the same drug can be manufactured as a generic, subject to other applicable regulatory requirements.
- The government can allow government use or compulsory licensing when access to medicines becomes a public concern.
Actionable Advice for Taxpayers / Founders:If your business deals in medicines, track which products are near patent expiry or facing licensing action, and check the current rules with your compliance advisor before planning any launch.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: